Results 161 to 170 of about 28,422 (269)

OMALIZUMAB FOR CHILDREN WITH BRONCHIAL ASTHMA: INDICATIONS TO APPLICATION

Педиатрическая фармакология, 2007
Antibodies to IgE are a totally new class of medications currently used to enhance the supervision over severe persistent atopic bronchial asthma. Omalizumab is the most well studied, first and only medication of this group, which is recommended for the ...
T.V. Kulichenko
doaj  

Metabolomics of asthma [PDF]

, 2014
Amaral, AFS
core   +1 more source

Bullous Wells’ syndrome successfully treated with omalizumab

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 5, Page 657-659, May 2026.
Giulia Ciccarese, William Andrew Rosato, Francesco Drago, Alexandre Raphael Meduri, Francesca Ambrogio, Aurora De Marco, Gerardo Cazzato, Caterina Foti   +7 more
wiley   +1 more source

Care pathways for the selection of a biologic in severe asthma [PDF]

, 2017
Bousquet, Jean, Brusselle, Guy, Buhl, Roland, Busse, William W, Cruz, Alvaro A, Djukanovic, Ratko, Domingo, Christian, Gow, Andrew Menzies, Hanania, Nicola A, Humbert, Marc, Phipatanakul, Wanda, Wahn, Ulrich, Wechsler, Michael E   +12 more
core   +2 more sources

Olipudase alfa IgE‐mediated anaphylaxis prevented by omalizumab and tailored desensitization in a child with acid sphingomyelinase deficiency

Pediatric Allergy and Immunology, Volume 37, Issue 5, May 2026.
Laura Fiori, Veronica Maria Tagi, Silvia Beretta, Chiara Montanari, Ilenia Pia Greco, Gianvincenzo Zuccotti, Enza D'Auria   +6 more
wiley   +1 more source

Real-life lessons on omalizumab and food allergy: The potential for unexplored outcomes. [PDF]

World Allergy Organ J
Lo Scalzo L, Galletta F, Cafarotti A, Nurmatov U, Klimek L, Fiocchi A, Arasi S.   +6 more
europepmc   +1 more source

Efficacy predictions for omalizumab treatment based on basophil CD203c expression in patients with allergic rhinitis by basophil activation test -- a real-life, pilot study. [PDF]

World Allergy Organ J
Zhao Z, Chen H, Liu T, Hong J, Deng Y, Hua Q.   +5 more
europepmc   +1 more source

Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review. [PDF]

, 2014
D'Amato G, D'Amato M., Liccardi G, MOLINO, ANTONIO, Salzillo A, SANDUZZI ZAMPARELLI, ALESSANDRO, STANZIOLA, ANNA AGNESE, Vatrella A, Vitale C   +8 more
core   +1 more source

Editorial: A new era in the treatment of food allergy. [PDF]

Front Immunol
Umetsu DT.
europepmc   +1 more source

Toward personalized prediction: a multicenter machine learning model for omalizumab response duration in moderate-to-severe perennial allergic rhinitis. [PDF]

Front Allergy
Miao Z, Dong L, Liu J, Li L, Dong X, Zhang S, Zhu R, Deng Y.   +7 more
europepmc   +1 more source